Liquid enrichment culture medium for fusobacterium nucleatum in human excrement and preparation method of liquid enrichment culture medium

Through the use of liquid bacterial culture medium, specific components and autoclave technology, the problem of separation of Flora nucleus in feces is solved, efficient and specific culture is achieved, and the operation is simplified and the cost is reduced. Rectal cancer research provides reliable experimental materials.

CN118995470APending Publication Date: 2024-11-22CHONGQING JIANGJIN DISTRICT CENT HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410930051.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-11
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The prior art is difficult to effectively isolate and cultivate F.nucleatum in human feces, especially because of the diverse bacterial species and similar colony morphology in feces, which leads to difficulty in separation, time-consuming and costly separation.

Method used

Provide a liquid bacterial culture medium, including distilled water, mixed peptone, resazurin, Tween, sodium bicarbonate, NaCl, agar, yeast extract, heme chloride, vitamin K, threonine, soluble pyrophosphate, The combination of soluble starch, glucose, sodium succinate and specific antibiotics inhibits the growth of other bacteria and promotes the growth of F.nucleatum through autoclaving and pH regulation.

Benefits of technology

The number and culture positivity rate of F.nucleatum were significantly improved, the specific culture of F.nucleatum was enhanced, the operation process was simplified, the cost was reduced, and reliable experimental materials were provided for the research of diseases such as colorectal cancer.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004939360400000041
    Figure BDA0004939360400000041
  • Figure BDA0004939360400000051
    Figure BDA0004939360400000051
Patent Text Reader

Abstract

The invention discloses a liquid enrichment medium for fusobacterium nucleatum in human excrement and a preparation method of the liquid enrichment medium. The culture medium is characterized by comprising mixed peptone, resazurin, tween-20, sodium bicarbonate, NaCl, agar, a yeast extract, hemin, vitamin K, threonine, soluble pyrophosphoric acid, soluble starch, glucose, sodium succinate, sodium pyruvate and 2 ml of a 1% neutral red aqueous solution. The preparation method comprises the following steps: adding the components into distilled water, soaking for 10 minutes, stirring while heating, and boiling for 1 minute. Adjusting the pH value to 8.0 + / -0.2 (25 DEG C), and then performing autoclaved sterilization at 121 DEG C for 15 minutes. And when the culture medium is cooled to 50-60 DEG C, adding antibiotics. And finally, packaging the culture medium into a sterilized test tube. The method has the beneficial effects that the culture positive rate is increased, infectious microbes are effectively inhibited, the operation is simple and convenient, and a more reliable experimental material is provided for research on related diseases such as colorectal cancer.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biotechnology, and in particular to a liquid bacterial enrichment culture medium for Fusobacterium nucleatum in human feces and a preparation method thereof. Background Art

[0002] Fusobacterium nucleatum (F.nucleatum) is a non-spore, Gram-negative anaerobic bacterium that is widely found in the human oral cavity and intestines. In recent years, with the continuous advancement of microbiome and bioinformatics analysis technology, people have gradually realized the close connection between intestinal flora and colorectal cancer (CRC). It is worth noting that high abundance of F.nucleatum has been shown to be significantly associated with an increased risk of CRC, and the risk of colorectal cancer in infected people is 3.5 times that of uninfected people. In addition, F.nucleatum is significantly enriched in tissue and fecal samples of CRC patients, indicating that there is a close association between this bacterium and the occurrence, development and drug resistance of CRC, and the load of F.nucleatum in patients has a significant positive correlation with poor prognosis.

[0003] Given the important role of F. nucleatum in the occurrence and development of CRC, effective isolation and culture of F. nucleatum and evaluation of its drug sensitivity are crucial for the treatment of CRC patients infected with this bacterium. However, the culture methods commonly used in current laboratories cannot meet the needs of isolation and culture, such as solid culture media such as CDC anaerobic blood agar and FAA fastidious anaerobic agar. Due to the variety of bacteria in patient feces (including Streptococcus, Bacteroides, Veillonella and other Fusobacteria, Staphylococci, Enterobacteriaceae and Enterococci, etc.), the non-selectivity of these culture media makes the specific isolation of F. nucleatum difficult. In addition, the colony morphology of F. nucleatum is similar to that of other bacteria, making it difficult to distinguish with the naked eye, and the further smear, staining and identification process is time-consuming, labor-intensive and costly. Summary of the invention

[0004] In view of the deficiencies in the above-mentioned prior art, the present invention provides a liquid enrichment culture medium for Fusobacterium nucleatum in human feces and a preparation method thereof, which can not only increase the number of F. nucleatum, but also has the ability to inhibit the growth of other miscellaneous bacteria, thereby achieving efficient and specific cultivation of F. nucleatum.

[0005] In order to achieve the above object, the present invention adopts the following technical solutions:

[0006] A liquid enrichment medium for Fusobacterium nucleatum in human feces, characterized in that it comprises the following components: 1L of distilled water, 1-35g of mixed peptone, 0.001g of resazurin, 0.1-5ml of Tween, 0-1g of sodium bicarbonate, 0-10g of NaCl, 1-20g of agar, 0-10g of yeast extract, 0-1g of hemin chloride, 0-1g of vitamin K, 0-5g of threonine, 0-2g of soluble pyrophosphate, 0-5g of soluble starch, 0-5g of glucose, 0-2g of sodium succinate, 0-5g of sodium pyruvate, and 0-1g of antibiotics.

[0007] Furthermore, the antibiotic is one or a combination of two or more of aminoglycoside antibiotics, linezolid, vancomycin, and amphotericin.

[0008] Further, the invention comprises the following components: 1L of distilled water, 23g of mixed peptone, 0.001g of resazurin, 1ml of Tween, 0.4g of sodium bicarbonate, 5g of NaCl, 12g of agar, 5g of yeast extract, 0.01g of hemin chloride, 0.01g of vitamin K, 1g of threonine, 0.25g of soluble pyrophosphate, 1g of soluble starch, 1g of glucose, 0.5g of sodium succinate, 1g of sodium pyruvate, 2ml of 1% neutral red aqueous solution, 32mg of aminoglycoside antibiotics, 32mg of linezolid, 32mg of vancomycin, and 4mg of amphotericin.

[0009] The present invention also aims to provide a method for preparing a liquid enrichment medium for Fusobacterium nucleatum in human feces, characterized in that it comprises the following steps:

[0010] S1. Weigh or measure 23.0 g of mixed peptone, 0.001 g of resazurin, 1.0 ml of Tween-20, 0.4 g of sodium bicarbonate, 5.0 g of NaCl, 12.0 g of agar, 5.0 g of yeast extract, 0.01 g of hemin, 0.01 g of vitamin K, 1.0 g of threonine, 0.25 g of soluble pyrophosphate, 1.0 g of soluble starch, 1.0 g of glucose, 0.5 g of sodium succinate, 1.0 g of sodium pyruvate, and 2 ml of 1% neutral red aqueous solution, and add the above ingredients into 1000 L of distilled water, soak for 10 min, and boil for one minute while heating and stirring;

[0011] S2. At 25°C, adjust the pH value of the solution to 8.0±0.2;

[0012] S3, sterilize the solution by high pressure sterilization at 121°C for 15 min;

[0013] S4. When the solution is cooled to 50°C-60°C, 32.0 mg of aminoglycoside antibiotics, 32.0 mg of linezolid, 32.0 mg of vancomycin, and 4.0 mg of amphotericin are added and stirred evenly to obtain a liquid culture medium;

[0014] S5. Pour the culture medium into sterilized test tubes, 5 ml of liquid culture medium into each test tube, and quickly plug the rubber stopper for later use.

[0015] The beneficial effects of the present invention include: 1. Improving the culture positive rate: Through the treatment of the liquid enrichment medium of the present invention, the number of F. nucleatum in the stool specimen can be significantly increased, thereby improving the culture positive rate on the subsequent solid culture medium. This is crucial for the accurate detection and identification of F. nucleatum, especially in clinical diagnosis and disease monitoring.

[0016] 2. Inhibition of other bacteria: The present invention effectively inhibits the growth of other bacteria in feces through a specific formula, thereby reducing the interference of other bacteria on F. nucleatum culture. This not only improves the specificity of culture, but also makes subsequent analysis and identification more accurate and efficient.

[0017] 3. Easy operation: Compared with the traditional direct solid culture, the liquid enrichment culture medium provided by the present invention is used as a pre-treatment step, which is easier to operate and does not require complicated smearing, staining and identification processes, thus reducing the difficulty and cost of experimental operation.

[0018] 4. Promote research and application: By improving the culture efficiency and positive rate of F.nucleatum, the present invention provides more reliable experimental materials for the research of colorectal cancer and other related diseases, which helps to promote the research progress of related diseases and the accuracy of clinical application. At the same time, it also provides strong support for the development of drugs and treatment methods for F.nucleatum. DETAILED DESCRIPTION

[0019] The present invention will be further described in detail below with reference to specific embodiments.

[0020] Example 1

[0021] Add 1g of mixed peptone, 0.001g of resazurin, 0.1ml of Tween-20, and 1g of agar (the agar here is mainly used as a thickener in the liquid culture medium and does not affect the liquid properties of the culture medium) to a container containing 1000ml of distilled water and soak for 10min. Boil for 1min while heating and stirring to completely dissolve it. Adjust the pH to 8.0±0.2 (25℃), and sterilize it at 121℃ for 15min. When the culture medium is cooled to 50-60℃, add antibiotics, 1mg of aminoglycoside antibiotics, 1mg of linezolid or 1mg of vancomycin, and 0.1mg of amphotericin. After stirring evenly, encapsulate it in a sterilized test tube, which can be divided into various specifications of 1-10ml / tube according to needs, and quickly plug the rubber stopper of the liquid culture medium. In this way, a liquid enrichment culture medium for Fusobacterium nucleatum can be obtained.

[0022] Example 2

[0023] Mixed peptone 23.0g, resazurin 0.001g, Tween-20 1.0ml, sodium bicarbonate 0.4g, NaCl 5.0g, agar 12.0g, yeast extract 5.0g, hemin 0.01g, vitamin K 0.01g, threonine 1.0g, soluble pyrophosphate 0.25g, soluble starch 1.0g, glucose 1.0g, sodium succinate 0.5g, sodium pyruvate 1.0g, 1% neutral red aqueous solution 2ml were added to a container containing 1000ml of distilled water, soaked for 10min, heated and stirred, boiled for 1min to ensure that all ingredients were completely dissolved. Then, the pH was adjusted to 8.0±0.2 (25°C), and then sterilized at 121°C for 15min. When the culture medium is cooled to 50-60°C, antibiotics are added, including 32.0 mg of aminoglycoside antibiotics, 32.0 mg of linezolid, 32.0 mg of vancomycin, and 4.0 mg of amphotericin, and stirred evenly. Finally, the culture medium is packaged into sterile test tubes, each tube is about 5.0 ml, and the rubber stopper of the liquid culture medium is quickly plugged. Thus, a liquid enrichment medium for Fusobacterium nucleatum can be obtained.

[0024] Example 3

[0025] Add 35g of mixed peptone, 0.001g of resazurin, 5ml of Tween, 1g of sodium bicarbonate, 10g of NaCl, 20g of agar, 10g of yeast extract, 1g of hemin, 1g of vitamin K, 5g of threonine, 2g of soluble pyrophosphate, 5g of soluble starch, 5g of glucose, 2g of sodium succinate, and 5g of sodium pyruvate to a container containing 1000ml of distilled water and soak for 10min, stir while heating, and boil for 1min to completely dissolve; adjust the pH to 8.0±0.2 (25℃), and sterilize at 121℃ for 15min; when the culture medium is cooled to 50-60℃, add 32mg of antibiotics-aminoglycoside antibiotics, 32mg of linezolid or 32mg of vancomycin, and 4mg of amphotericin, and package them into sterilized test tubes, about 10ml / tube, and quickly plug the rubber stopper of the liquid culture medium. In this way, a liquid enrichment culture medium for Fusobacterium nucleatum can be obtained.

[0026] The above three embodiments were tested by comparing the control groups to verify their effectiveness.

[0027] Positive control group: The standard strain of Fusobacterium nucleatum (ATCC25586) was appropriately diluted and adjusted to a concentration of 0.5 Mcf for use in subsequent experiments.

[0028] Experimental Group 1:

[0029] 1. Take 5.0 g of fresh feces and sterilize it by high pressure.

[0030] 2. Add 100.0 μl of the bacterial suspension prepared in the positive control group and mix thoroughly with the feces.

[0031] 3. Use a 10.0 μl inoculation loop to pick up 2 loops of the mixed stool sample and inoculate them into the liquid enrichment medium of the present invention.

[0032] 4. Place the inoculated culture medium in an incubator at 36°C for 1 hour.

[0033] 5. The culture was then transferred to Columbia blood agar plates and cultured anaerobically for 3 days.

[0034] 6. Observe and record the growth of Fusobacterium nucleatum to verify the effectiveness of the culture medium.

[0035] Negative control group: normal saline.

[0036] The positive control group and the negative control group were cultured and observed according to steps 3-6 of experimental group one.

[0037] The growth of bacteria for validation is shown in Table 1.

[0038] Table 1

[0039]

[0040]

[0041] It can be seen from the above results that the liquid enrichment culture medium provided in the three embodiments of the present invention is suitable for the growth of Fusobacterium nucleatum and can significantly promote the growth and reproduction of Fusobacterium nucleatum. Among them, the best culture medium ratio can be obtained as Example 2.

[0042] The above three examples of control groups were specifically verified.

[0043] Positive control group: The standard strain of Fusobacterium nucleatum (ATCC25586) was appropriately diluted and adjusted to a concentration of 0.5 Mcf for use in subsequent experiments.

[0044] Experimental Group 2:

[0045] 1. Take 100 μl of the bacterial suspension prepared in the positive control group, add 0.5 Mcf of other common fecal bacteria (Streptococcus, Bacteroides, Veillonella and other Fusobacteria, Staphylococcus, Enterobacteriaceae and Enterococcus, etc.) and mix thoroughly.

[0046] 2. Use a 10 μl inoculation loop to pick up 2 loops of the mixed bacterial solution sample and inoculate them into the liquid enrichment culture medium of Example 2 of the present invention.

[0047] 3. Place the inoculated culture medium in a common incubator at 36°C and incubate for 1 hour.

[0048] 4. The culture was then transferred to Columbia blood agar plates and cultured anaerobically for 3 days.

[0049] 5. Observe and record the growth of Fusobacterium nucleatum to verify the effectiveness of the culture medium.

[0050] Negative control group: normal saline.

[0051] The growth of specific verification bacteria is shown in Table 2.

[0052] Table 2

[0053] Group Growth of Fusobacterium nucleatum on Columbia blood agar Example 2 (experimental group 2) 3+ Negative control (normal saline) - Positive control (standard strain) 3+

[0054] From the results in Table 2, it can be seen that the liquid bacterial enrichment medium of the present invention has a good inhibitory effect on miscellaneous bacteria.

[0055] Practical application effect verification

[0056] Experimental group three:

[0057] 1. Collect stool samples from patients with colorectal cancer and select samples positive for Fusobacterium nucleatum nucleic acid for experiments.

[0058] 2. Use a 10 μl inoculation loop to pick up 2 loops of stool sample and inoculate them into the liquid enrichment medium of the present invention.

[0059] 3. Place the inoculated culture medium in a common incubator at 36°C and incubate for 1 hour.

[0060] 4. The culture was then transferred to Columbia blood agar plates and cultured anaerobically for 3 days.

[0061] 5. Observe and record the growth of Fusobacterium nucleatum to verify the effectiveness of the culture medium.

[0062] The actual application verification of bacterial growth is shown in Table 2.

[0063] Table 2

[0064] Group Growth of Fusobacterium nucleatum on Columbia blood agar Example 2 (experimental group three) 3+ Negative control (normal saline) - Positive control (standard strain) 3+

[0065] It can be seen from the above results that, by combining with clinical samples, the culture medium of the present invention can also significantly promote the growth and reproduction of Fusobacterium nucleatum and have a good inhibitory effect on miscellaneous bacteria in practical applications.

[0066] in conclusion

[0067] 1. Special composition of enrichment medium:

[0068] A specific antibiotic combination was introduced, including aminoglycoside antibiotics, vancomycin, and amphotericin. This combination can effectively inhibit about 90% of intestinal bacteria and significantly improve the isolation efficiency of F. nucleatum.

[0069] The dosage range of antibiotics is precisely defined to ensure that while inhibiting foreign bacteria, it does not affect the growth of F. nucleatum. This dosage is the optimal value determined through careful experiments.

[0070] Tween-20 is added, which can effectively promote the dispersion of bacteria and solve the problem of adhesion of F. nucleatum and other bacteria, making it easier to obtain pure single colonies when transferring to solid culture medium.

[0071] 2. Adjustment of pH value of culture medium:

[0072] By adjusting the pH value of the culture medium to alkaline, an unfavorable growth environment for most bacteria is created. At the same time, the ability of F. nucleatum to survive in alkaline conditions is utilized to further eliminate bacteria that cannot be completely inhibited by antibiotics.

[0073] 3. Accurate control of bacterial enrichment time:

[0074] Taking advantage of the fact that F. nucleatum has stronger oxygen tolerance than other anaerobic bacteria, by precisely controlling the bacterial growth time within 1 hour, we effectively removed anaerobic bacteria that still survive in antibiotics and alkaline environments, further improving the separation purity and efficiency of F. nucleatum.

[0075] 4. Innovative strategy for inhibiting bacteria:

[0076] By comprehensively using antibiotics, pH adjustment, and bacterial growth time control, a systematic strategy for inhibiting foreign bacteria was formed, which significantly improved the isolation purity of F. nucleatum.

[0077] 5. Optimization of culture medium formulation:

[0078] Through in-depth research and optimization of the culture medium formula, precise control of the growth environment of F. nucleatum is achieved, providing it with optimal growth conditions, thereby improving the culture efficiency and success rate.

[0079] 6. Improve experimental operability and repeatability:

[0080] Through the careful design of culture medium composition and condition control, the experimental operation is made simpler and the repeatability of the experiment is improved, providing more reliable technical support for the research and application of F. nucleatum.

[0081] The technical solutions provided by the embodiments of the present invention are introduced in detail above. Specific examples are used herein to illustrate the principles and implementation methods of the embodiments of the present invention. The description of the above embodiments is only applicable to help understand the principles of the embodiments of the present invention. At the same time, for those skilled in the art, according to the embodiments of the present invention, there will be changes in the specific implementation methods and application scopes. In summary, the content of this specification should not be understood as limiting the present invention.

Claims

1. A liquid culture medium for enriching Fusobacterium nucleatum in human feces, characterized in that: The invention comprises the following components: 1L of distilled water, 1-35g of mixed peptone, 0.001g of resazurin, 0.1-5ml of Tween, 0-1g of sodium bicarbonate, 0-10g of NaCl, 1-20g of agar, 0-10g of yeast extract, 0-1g of hemin chloride, 0-1g of vitamin K, 0-5g of threonine, 0-2g of soluble pyrophosphate, 0-5g of soluble starch, 0-5g of glucose, 0-2g of sodium succinate, 0-5g of sodium pyruvate and 0-1g of antibiotic.

2. A liquid culture medium for enriching Fusobacterium nucleatum in human feces according to claim 1, characterized in that: The antibiotic is one or a combination of two or more of aminoglycoside antibiotics, linezolid, vancomycin, and amphotericin.

3. A liquid culture medium for enriching Fusobacterium nucleatum in human feces according to claim 2, characterized in that: It includes the following components: 1L of distilled water, 23g of mixed peptone, 0.001g of resazurin, 1ml of Tween, 0.4g of sodium bicarbonate, 5g of NaCl, 12g of agar, 5g of yeast extract, 0.01g of hemin chloride, 0.01g of vitamin K, 1g of threonine, 0.25g of soluble pyrophosphate, 1g of soluble starch, 1g of glucose, 0.5g of sodium succinate, 1g of sodium pyruvate, 2ml of 1% neutral red aqueous solution, 32mg of aminoglycoside antibiotics, 32mg of linezolid, 32mg of vancomycin, and 4mg of amphotericin.

4. A method for preparing a liquid enrichment medium for Fusobacterium nucleatum in human feces, characterized in that: The following steps are included: S1. Weigh or measure 23.0 g of mixed peptone, 0.001 g of resazurin, 1.0 ml of Tween-20, 0.4 g of sodium bicarbonate, 5.0 g of NaCl, 12.0 g of agar, 5.0 g of yeast extract, 0.01 g of hemin, 0.01 g of vitamin K, 1.0 g of threonine, 0.25 g of soluble pyrophosphate, 1.0 g of soluble starch, 1.0 g of glucose, 0.5 g of sodium succinate, 1.0 g of sodium pyruvate, and 2 ml of 1% neutral red aqueous solution, and add the above ingredients into 1000 L of distilled water, soak for 10 min, and boil for one minute while heating and stirring; S2. At 25°C, adjust the pH value of the solution to 8.0±0.2; S3, sterilize the solution by high pressure sterilization at 121°C for 15 min; S4. When the solution is cooled to 50°C-60°C, 32.0 mg of aminoglycoside antibiotics, 32.0 mg of linezolid, 32.0 mg of vancomycin, and 4.0 mg of amphotericin are added and stirred evenly to obtain a liquid culture medium; S5. Pour the culture medium into sterilized test tubes, 5 ml of liquid culture medium into each test tube, and quickly plug the rubber stopper for later use.